SAB Biotherapeutics, Inc.
SABS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $1.32M | −100% |
| Operating income | −$49.0M | −$42.9M | −14.1% |
| Net income | $4.26M | −$34.1M |
Questions
- What was SAB Biotherapeutics's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $1.32M a year earlier, per its 10-K filed Mar 2026.
- Was SAB Biotherapeutics profitable in FY2025?
- Yes: net income was $4.26M and operating income −$49.0M in FY2025.